Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
4.100
+0.230 (5.94%)
Nov 21, 2025, 3:19 PM EST - Market open

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead.

It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs.

Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Ekso Bionics Holdings, Inc.
Ekso Bionics Holdings logo
CountryUnited States
Founded2005
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees66
CEOScott Davis

Contact Details

Address:
101 Glacier Point, Suite A
San Rafael, California 94901
United States
Phone510 984 1761
Websiteeksobionics.com

Stock Details

Ticker SymbolEKSO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001549084
CUSIP Number282644400
ISIN NumberUS2826444000
SIC Code3569

Key Executives

NamePosition
Scott G. DavisChief Executive Officer and Director
Jerome WongChief Financial Officer and Corporate Secretary
Jason C. JonesChief Operating Officer
Lisa BentleyHead of Marketing
Ann CooksonHuman Resources Director
Foon Lim ChweePresident of APAC
Stephan AderholdSenior Vice President and GM of EMEA
Katherine StrausserPrincipal Controls Engineer

Latest SEC Filings

DateTypeTitle
Nov 7, 20258-KCurrent Report
Oct 30, 20258-KCurrent Report
Oct 29, 2025424B5Filing
Oct 28, 2025424B5Filing
Oct 28, 202510-QQuarterly Report
Oct 28, 20258-KCurrent Report
Sep 17, 20258-KCurrent Report
Aug 14, 2025SCHEDULE 13G/AFiling
Jul 28, 202510-QQuarterly Report
Jul 28, 20258-KCurrent Report